It suppressed the production of 2-HG in a dose-dependent manner and significantly inhibited growth of anaplastic oligodendroglioma cells harboring heterozygous IDH1/R132H mutation without influence on IDH1-wt patient-derived glioma cells. Here, IDH1 is linked to oligodendroglioma.